{
  "retracted": false,
  "timestamp": 1549411200000,
  "updates": [
    {
      "timestamp": 1585016265094,
      "identifier": {
        "doi": "10.1038/s41436-018-0258-3"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/gim.2018.31"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis"
}
